Biliopancreatic diversion with duodenal switch improves insulin sensitivity and secretion through caloric restriction

Obesity

Volumn 22, Issue 8, 2014, Pages 1838-1846

  Plourde, Charles Étienne ^a,b   Grenier Larouche, Thomas ^a,b   Caron Dorval, Dominique ^b   Biron, Simon ^b   Marceau, Simon ^b   Lebel, Stéfan ^b   Biertho, Laurent ^b   Tchernof, André ^b   Richard, Denis ^b   Carpentier, André C ^a  

^a Centre Hospitalier Universitaire de Sherbrooke   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; PANCREAS POLYPEPTIDE; PEPTIDE YY; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BILIOPANCREATIC BYPASS; CALORIC INTAKE; CALORIC RESTRICTION; CELL FUNCTION; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISPOSITION INDEX; FEMALE; GLUCOSE HOMEOSTASIS; HORMONE RESPONSE; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PANCREAS ISLET BETA CELL; PROTEIN ANALYSIS; RATING SCALE; ANALYSIS; BLOOD; COMPLICATION; CYTOLOGY; DUODENUM; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; MIDDLE AGED; OBESITY, MORBID; PILOT STUDY; SECRETION (PROCESS);

ADULT; BILIOPANCREATIC DIVERSION; BLOOD GLUCOSE; CALORIC RESTRICTION; DIABETES MELLITUS, TYPE 2; DUODENUM; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; OBESITY, MORBID; PEPTIDE YY; PILOT PROJECTS;

EID: 84905039330     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20771     Document Type: Article

References (37)

1. Mingrone G, Panunzi S, De GA, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012; 366: 1577-1585.
2. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-1737.
3. Mari A, Manco M, Guidone C, et al. Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function. Diabetologia 2006; 49: 2136-2143.
4. Guidone C, Manco M, Valera-Mora E, et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 2006; 55: 2025-2031.
5. Laferrere B,. Diabetes remission after bariatric surgery: is it just the incretins? Int J Obes (Lond) 2011; 35 Suppl 3: S22-S25.
6. Bradley D, Magkos F, Klein S,. Effects of bariatric surgery on glucose homeostasis and type 2 diabetes. Gastroenterology 2012; 143: 897-912.
7. Dirksen C, Jorgensen NB, Bojsen-Moller KN, et al. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. Diabetologia 2012; 55: 1890-1901.
8. Rhee NA, Vilsboll T, Knop FK,. Current evidence for a role of GLP-1 in Roux-en-Y gastric bypass-induced remission of type 2 diabetes. Diabetes Obes Metab 2012; 14: 291-298.
9. Bradley D, Conte C, Mittendorfer B, et al. Gastric bypass and banding equally improve insulin sensitivity and beta cell function. J Clin Invest 2012; 122: 4667-4674.
10. Isbell JM, Tamboli RA, Hansen EN, et al the importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care 2010; 33: 1438-1442.
11. Jackness C, Karmally W, Febres G, et al. Very Low-Calorie Diet Mimics the Early Beneficial Effect of Roux-en-Y Gastric Bypass on Insulin Sensitivity and beta-Cell Function in Type 2 Diabetic Patients. Diabetes 2013; 62: 3027-3032.
12. Marceau P, Hould FS, Simard S, et al. Biliopancreatic diversion with duodenal switch. World J Surg 1998; 22: 947-954.
13. Marceau P, Biron S, Hould FS, et al. Duodenal switch improved standard biliopancreatic diversion: a retrospective study. Surg Obes Relat Dis 2009; 5: 43-47.
14. Goulet J, Nadeau G, Lapointe A, Lamarche B, Lemieux S,. Validity and reproducibility of an interviewer-administered food frequency questionnaire for healthy French-Canadian men and women. Nutr J 2004; 3: 13.
15. Richardson MT, Leon AS, Jacobs DR, Jr., Ainsworth BE, Serfass R,. Comprehensive evaluation of the Minnesota Leisure Time Physical Activity Questionnaire. J Clin Epidemiol 1994; 47: 271-281.
16. Matsuda M, DeFronzo RA,. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462-1470.
17. Maki KC, McKenney JM, Farmer MV, Reeves MS, Dicklin MR,. Indices of insulin sensitivity and secretion from a standard liquid meal test in subjects with type 2 diabetes, impaired or normal fasting glucose. Nutr J 2009; 8: 22.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC,. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
19. Carpentier AC, Bourbonnais A, Frisch F, Giacca A, Lewis GF,. Plasma nonesterified Fatty Acid intolerance and hyperglycemia are associated with intravenous lipid-induced impairment of insulin sensitivity and disposition index. J Clin Endocrinol Metab 2010; 95: 1256-1264.
20. Bergman RN, Ader M, Huecking K, Van Citters G,. Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes 2002; 51 Suppl 1: S212-S220.
21. Kahn SE, the relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 2003; 46: 3-19.
22. Laferrere B, Teixeira J, McGinty J, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2008; 93: 2479-2485.
23. Iesari S, le Roux CW, De Gaetano A, Manco M, Nanni G, Mingrone G,. Twenty-four hour energy expenditure and skeletal muscle gene expression changes after bariatric surgery. J Clin Endocrinol Metab 2013; 98: E321-327.
24. Jazet IM, Pijl H, Frolich M, Romijn JA, Meinders AE,. Two days of a very low calorie diet reduces endogenous glucose production in obese type 2 diabetic patients despite the withdrawal of blood glucose-lowering therapies including insulin. Metabolism 2005; 54: 705-712.
25. Kirk E, Reeds DN, Finck BN, Mayurranjan SM, Patterson BW, Klein S,. Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology 2009; 136: 1552-1560.
26. Dutia R, Brakoniecki K, Bunker P, et al. Limited recovery of beta-cell function after gastric bypass despite clinical diabetes remission. Diabetes 2013; 63: 1214-1223.
27. Salehi M, Prigeon RL, D'Alessio DA,. Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans. Diabetes 2011; 60: 2308-2314.
28. Hansen EN, Tamboli RA, Isbell JM, et al. Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery. Am J Physiol Gastrointest Liver Physiol 2011; 300: G795-G802.
29. Hansen KB, Vilsboll T, Bagger JI, Holst JJ, Knop FK,. Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects. J Clin Endocrinol Metab 2012; 97: 1363-1370.
30. Utzschneider KM, Carr DB, Barsness SM, Kahn SE, Schwartz RS,. Diet-induced weight loss is associated with an improvement in beta-cell function in older men. J Clin Endocrinol Metab 2004; 89: 2704-2710.
31. Kitabchi AE, Temprosa M, Knowler WC, et al. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes 2005; 54: 2404-2414.
32. Geloneze B, Geloneze SR, Chaim E, et al. Metabolic surgery for non-obese type 2 diabetes: incretins, adipocytokines, and insulin secretion/resistance changes in a 1-year interventional clinical controlled study. Ann Surg 2012; 256: 72-78.
33. Klein S, Fabbrini E, Patterson BW, et al. Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes. Obesity 2012; 20: 1266-1272.
34. Vilsboll T, Christensen M, Junker AE, Knop FK, Gluud LL,. Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials. BMJ 2012; 344: d7771.
35. Cummings DE,. Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery. Int J Obes (Lond) 2009; 33 Suppl 1: S33-40.
36. Adami GF, Cordera R, Marinari G, Lamerini G, Andraghetti G, Scopinaro N,. Plasma ghrelin concentratin in the short-term following biliopancreatic diversion. Obes Surg 2003; 13: 889-892.
37. Kahleova H, Mari A, Nofrate V, et al. Improvement in beta-cell function after diet-induced weight loss is associated with decrease in pancreatic polypeptide in subjects with type 2 diabetes. J Diabetes Complications 2012; 26: 442-449.